{"parse":{"title":"Incremental cost-effectiveness ratio","pageid":265132,"revid":846906053,"text":{"*":"<div class=\"mw-parser-output\"><p>The <b>incremental cost-effectiveness ratio</b> (<b>ICER</b>) is a statistic used in <a href=\"/wiki/Cost-effectiveness_analysis\" title=\"Cost-effectiveness analysis\">cost-effectiveness analysis</a> to summarise the cost-effectiveness of a health care intervention. It is defined by the difference in cost between two possible interventions, divided by the difference in their effect. It represents the average incremental cost associated with 1 additional unit of the measure of effect. The ICER can be estimated as:\n</p><p><span class=\"mwe-math-element\"><span class=\"mwe-math-mathml-inline mwe-math-mathml-a11y\" style=\"display: none;\"><math xmlns=\"http://www.w3.org/1998/Math/MathML\"  alttext=\"{\\displaystyle ICER={\\frac {(C_{1}-C_{0})}{(E_{1}-E_{0})}}}\">\n  <semantics>\n    <mrow class=\"MJX-TeXAtom-ORD\">\n      <mstyle displaystyle=\"true\" scriptlevel=\"0\">\n        <mi>I</mi>\n        <mi>C</mi>\n        <mi>E</mi>\n        <mi>R</mi>\n        <mo>=</mo>\n        <mrow class=\"MJX-TeXAtom-ORD\">\n          <mfrac>\n            <mrow>\n              <mo stretchy=\"false\">(</mo>\n              <msub>\n                <mi>C</mi>\n                <mrow class=\"MJX-TeXAtom-ORD\">\n                  <mn>1</mn>\n                </mrow>\n              </msub>\n              <mo>&#x2212;<!-- \u2212 --></mo>\n              <msub>\n                <mi>C</mi>\n                <mrow class=\"MJX-TeXAtom-ORD\">\n                  <mn>0</mn>\n                </mrow>\n              </msub>\n              <mo stretchy=\"false\">)</mo>\n            </mrow>\n            <mrow>\n              <mo stretchy=\"false\">(</mo>\n              <msub>\n                <mi>E</mi>\n                <mrow class=\"MJX-TeXAtom-ORD\">\n                  <mn>1</mn>\n                </mrow>\n              </msub>\n              <mo>&#x2212;<!-- \u2212 --></mo>\n              <msub>\n                <mi>E</mi>\n                <mrow class=\"MJX-TeXAtom-ORD\">\n                  <mn>0</mn>\n                </mrow>\n              </msub>\n              <mo stretchy=\"false\">)</mo>\n            </mrow>\n          </mfrac>\n        </mrow>\n      </mstyle>\n    </mrow>\n    <annotation encoding=\"application/x-tex\">{\\displaystyle ICER={\\frac {(C_{1}-C_{0})}{(E_{1}-E_{0})}}}</annotation>\n  </semantics>\n</math></span><img src=\"https://wikimedia.org/api/rest_v1/media/math/render/svg/b042b2af8a46190f5506176e193d28e2f86a1c99\" class=\"mwe-math-fallback-image-inline\" aria-hidden=\"true\" style=\"vertical-align: -2.671ex; width:20.601ex; height:6.509ex;\" alt=\"ICER={\\frac  {(C_{{1}}-C_{{0}})}{(E_{{1}}-E_{{0}})}}\"/></span>,\n</p><p>where <span class=\"mwe-math-element\"><span class=\"mwe-math-mathml-inline mwe-math-mathml-a11y\" style=\"display: none;\"><math xmlns=\"http://www.w3.org/1998/Math/MathML\" alttext=\"{\\textstyle C_{1}}\">\n  <semantics>\n    <mrow class=\"MJX-TeXAtom-ORD\">\n      <mstyle displaystyle=\"false\" scriptlevel=\"0\">\n        <msub>\n          <mi>C</mi>\n          <mrow class=\"MJX-TeXAtom-ORD\">\n            <mn>1</mn>\n          </mrow>\n        </msub>\n      </mstyle>\n    </mrow>\n    <annotation encoding=\"application/x-tex\">{\\textstyle C_{1}}</annotation>\n  </semantics>\n</math></span><img src=\"https://wikimedia.org/api/rest_v1/media/math/render/svg/677a99cc6a1ac23ff88fc13fa384646a09857d76\" class=\"mwe-math-fallback-image-inline\" aria-hidden=\"true\" style=\"vertical-align: -0.671ex; width:2.716ex; height:2.509ex;\" alt=\"{\\textstyle C_{{1}}}\"/></span> and <span class=\"mwe-math-element\"><span class=\"mwe-math-mathml-inline mwe-math-mathml-a11y\" style=\"display: none;\"><math xmlns=\"http://www.w3.org/1998/Math/MathML\"  alttext=\"{\\displaystyle E_{1}}\">\n  <semantics>\n    <mrow class=\"MJX-TeXAtom-ORD\">\n      <mstyle displaystyle=\"true\" scriptlevel=\"0\">\n        <msub>\n          <mi>E</mi>\n          <mrow class=\"MJX-TeXAtom-ORD\">\n            <mn>1</mn>\n          </mrow>\n        </msub>\n      </mstyle>\n    </mrow>\n    <annotation encoding=\"application/x-tex\">{\\displaystyle E_{1}}</annotation>\n  </semantics>\n</math></span><img src=\"https://wikimedia.org/api/rest_v1/media/math/render/svg/7ac42446bcd2cbb76ec8fe2895635d328da22e26\" class=\"mwe-math-fallback-image-inline\" aria-hidden=\"true\" style=\"vertical-align: -0.671ex; width:2.769ex; height:2.509ex;\" alt=\"E_{{1}}\"/></span> are the cost and effect in the intervention group and where <span class=\"mwe-math-element\"><span class=\"mwe-math-mathml-inline mwe-math-mathml-a11y\" style=\"display: none;\"><math xmlns=\"http://www.w3.org/1998/Math/MathML\" alttext=\"{\\textstyle C_{0}}\">\n  <semantics>\n    <mrow class=\"MJX-TeXAtom-ORD\">\n      <mstyle displaystyle=\"false\" scriptlevel=\"0\">\n        <msub>\n          <mi>C</mi>\n          <mrow class=\"MJX-TeXAtom-ORD\">\n            <mn>0</mn>\n          </mrow>\n        </msub>\n      </mstyle>\n    </mrow>\n    <annotation encoding=\"application/x-tex\">{\\textstyle C_{0}}</annotation>\n  </semantics>\n</math></span><img src=\"https://wikimedia.org/api/rest_v1/media/math/render/svg/da652d4ed018af92030ab9fd4d0f23415f3653ca\" class=\"mwe-math-fallback-image-inline\" aria-hidden=\"true\" style=\"vertical-align: -0.671ex; width:2.716ex; height:2.509ex;\" alt=\"{\\textstyle C_{{0}}}\"/></span> and <span class=\"mwe-math-element\"><span class=\"mwe-math-mathml-inline mwe-math-mathml-a11y\" style=\"display: none;\"><math xmlns=\"http://www.w3.org/1998/Math/MathML\" alttext=\"{\\textstyle E_{0}}\">\n  <semantics>\n    <mrow class=\"MJX-TeXAtom-ORD\">\n      <mstyle displaystyle=\"false\" scriptlevel=\"0\">\n        <msub>\n          <mi>E</mi>\n          <mrow class=\"MJX-TeXAtom-ORD\">\n            <mn>0</mn>\n          </mrow>\n        </msub>\n      </mstyle>\n    </mrow>\n    <annotation encoding=\"application/x-tex\">{\\textstyle E_{0}}</annotation>\n  </semantics>\n</math></span><img src=\"https://wikimedia.org/api/rest_v1/media/math/render/svg/74e4cdd72c2df19fa65d3cabca0d0b7652fa7944\" class=\"mwe-math-fallback-image-inline\" aria-hidden=\"true\" style=\"vertical-align: -0.671ex; width:2.769ex; height:2.509ex;\" alt=\"{\\textstyle E_{{0}}}\"/></span> are the cost and effect in the control care group.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> Costs are usually described in monetary units, while effects can be measured in terms of health status or another outcome of interest. A common application of the ICER is in <a href=\"/wiki/Cost%E2%80%93utility_analysis\" title=\"Cost\u2013utility analysis\">cost-utility analysis</a>, in which case the ICER is synonymous with the cost per <a href=\"/wiki/Quality-adjusted_life_years\" class=\"mw-redirect\" title=\"Quality-adjusted life years\">quality-adjusted life year</a> (QALY) gained.\n</p>\n<h2><span class=\"mw-headline\" id=\"Use_as_a_decision_rule\">Use as a decision rule</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Incremental_cost-effectiveness_ratio&amp;action=edit&amp;section=1\" title=\"Edit section: Use as a decision rule\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The ICER can be used as a decision rule in resource allocation. If a decision-maker is able to establish a <a href=\"/wiki/Willingness-to-pay\" class=\"mw-redirect\" title=\"Willingness-to-pay\">willingness-to-pay</a> value for the outcome of interest, it is possible to adopt this value as a threshold. If for a given intervention the ICER is above this threshold it will be deemed too expensive and thus should not be funded, whereas if the ICER lies below the threshold the intervention can be judged cost-effective. This approach has to some extent been adopted in relation to QALYs; for example, the <a href=\"/wiki/National_Institute_for_Health_and_Care_Excellence\" title=\"National Institute for Health and Care Excellence\">National Institute for Health and Care Excellence</a> (NICE) adopts a nominal cost-per-QALY threshold of \u00a320,000 to \u00a330,000.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>   As such, the ICER facilitates comparison of interventions across various disease states and treatments. In 2009, NICE set the nominal cost-per-QALY threshold at \u00a350,000 for end-of-life care because dying patients typically benefit from any treatment for a matter of months, making the treatment's QALYs small.<sup id=\"cite_ref-:0_3-0\" class=\"reference\"><a href=\"#cite_note-:0-3\">&#91;3&#93;</a></sup> In 2016, NICE set the cost-per-QALY threshold at \u00a3100,000 for treatments for rare conditions because, otherwise,  drugs for a small number of patients would not be profitable.<sup id=\"cite_ref-:0_3-1\" class=\"reference\"><a href=\"#cite_note-:0-3\">&#91;3&#93;</a></sup> The use of ICERs therefore provides an opportunity to help contain <a href=\"/wiki/Health_care_costs\" class=\"mw-redirect\" title=\"Health care costs\">health care costs</a> while minimizing adverse health consequences.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> Treatments for patients who are near death offer few QALYs simply because the typical patient has only months left to benefit from treatment. They also provide to policy makers information on where resources should be allocated when they are limited.<sup id=\"cite_ref-DollarValue_5-0\" class=\"reference\"><a href=\"#cite_note-DollarValue-5\">&#91;5&#93;</a></sup> As health care costs have continued to rise, many new <a href=\"/wiki/Clinical_trials\" class=\"mw-redirect\" title=\"Clinical trials\">clinical trials</a> are attempting to integrate ICER into results to provide more evidence of potential benefit.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Controversies\">Controversies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Incremental_cost-effectiveness_ratio&amp;action=edit&amp;section=2\" title=\"Edit section: Controversies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Many people feel that basing health care interventions on cost-effectiveness is a type of <a href=\"/wiki/Health_care_rationing\" title=\"Health care rationing\">health care rationing</a> and have expressed concern that using ICER will limit the amount or types of treatments and interventions available to patients.<sup id=\"cite_ref-DollarValue_5-1\" class=\"reference\"><a href=\"#cite_note-DollarValue-5\">&#91;5&#93;</a></sup> Currently, the <a href=\"/wiki/National_Institute_for_Health_and_Care_Excellence\" title=\"National Institute for Health and Care Excellence\">National Institute for Health and Care Excellence</a> (NICE) of England's <a href=\"/wiki/National_Health_Service\" title=\"National Health Service\">National Health Service</a> (NHS) uses cost-effectiveness studies to determine if new treatments or therapies at the prices proposed by manufacturers provide better value relative to the treatment that is currently in use. With the number of cost-effectiveness studies rising, it is possible for a cost-effectiveness ratio threshold to be established in other countries for the acceptance of reimbursement or formulary listing at a given price. \n</p><p>Research by York University identified that cost per Quality adjusted life year for changes in existing NHS spend in 2008 was \u00a312,936 leading to concerns new treatments approved by NICE at \u00a330,000 per Quality adjusted life year are less cost-effective than spend on existing treatments.  This would mean that diverting NHS spend to new treatments would forgo more than 2 quality adjusted life years for every year gained from the new treatment. [Methods for the estimation of the NICE cost effectiveness threshold. Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M. <i>Health Technology Assessment </i>2015;19(14):doi10.3310/hta19140]\n</p><p>The concern that ICER may lead to rationing has affected policy makers in the United States. The <a href=\"/wiki/Patient_Protection_and_Affordable_Care_Act\" title=\"Patient Protection and Affordable Care Act\">Patient Protection and Affordable Care Act</a> of 2010 provided for the creation of the independent <a href=\"/wiki/Patient-Centered_Outcomes_Research_Institute\" title=\"Patient-Centered Outcomes Research Institute\">Patient-Centered Outcomes Research Institute</a> (PCORI).  The Senate Finance Committee in writing PPACA forbade PCORI from using \"dollars-per-quality adjusted life year (or similar measure that discounts the value of a life because of an individual's disability) as a threshold to establish what type of health care is cost effective or recommended\".<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Incremental_cost-effectiveness_ratio&amp;action=edit&amp;section=3\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\">What is the incremental cost-effectiveness ratio (ICER)? GaBI Online. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.gabionline.net/Generics/General/What-is-the-incremental-cost-effectiveness-ratio-ICER\">[1]</a>. Accessed 20 March 2012.</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Appleby, John; Devlin, Nancy; Parkin, David (2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bmj.com/content/335/7616/358\">\"NICE's cost effectiveness threshold\"</a>. <i>BMJ</i>. <b>335</b>: 358\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/bmj.39308.560069.BE\">10.1136/bmj.39308.560069.BE</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1952475\">1952475</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17717337\">17717337</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=NICE%27s+cost+effectiveness+threshold&amp;rft.volume=335&amp;rft.pages=358-9&amp;rft.date=2007&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1952475&amp;rft_id=info%3Apmid%2F17717337&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.39308.560069.BE&amp;rft.aulast=Appleby&amp;rft.aufirst=John&amp;rft.au=Devlin%2C+Nancy&amp;rft.au=Parkin%2C+David&amp;rft_id=http%3A%2F%2Fwww.bmj.com%2Fcontent%2F335%2F7616%2F358&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncremental+cost-effectiveness+ratio\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://pharmaphorum.com/views-and-analysis/three-nice-thresholds-for-cost-effectiveness-does-that-make-sense/\">\"Three NICE thresholds for cost-effectiveness: does that make sense? - Pharmaphorum\"</a>. <i>Pharmaphorum</i>. 2016-11-25<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-01-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmaphorum&amp;rft.atitle=Three+NICE+thresholds+for+cost-effectiveness%3A+does+that+make+sense%3F+-+Pharmaphorum&amp;rft.date=2016-11-25&amp;rft_id=http%3A%2F%2Fpharmaphorum.com%2Fviews-and-analysis%2Fthree-nice-thresholds-for-cost-effectiveness-does-that-make-sense%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncremental+cost-effectiveness+ratio\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Orszag PR, Ellis P (2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nejm.org/doi/full/10.1056/NEJMp078190\">\"Addressing rising health care costs\u2014A view from the Congressional Budget Office\"</a>. <i>N Engl J Med</i>. <b>357</b>: 1885\u20131887. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMp078190\">10.1056/NEJMp078190</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Addressing+rising+health+care+costs%E2%80%94A+view+from+the+Congressional+Budget+Office&amp;rft.volume=357&amp;rft.pages=1885-1887&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMp078190&amp;rft.aulast=Orszag&amp;rft.aufirst=PR&amp;rft.au=Ellis%2C+P&amp;rft_id=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMp078190&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncremental+cost-effectiveness+ratio\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-DollarValue-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-DollarValue_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-DollarValue_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Cost-effective Medical Treatment: Putting an Updated Dollar Value on Human Life. Knowledge@Wharton, 30 April 2008. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://knowledge.wharton.upenn.edu/article.cfm?articleid=1949\">[2]</a>. Accessed 20 March 2012.</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S (2005). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ispor.org/workpaper/research_practices/Good_Research_Practices-Cost_Effectiveness_Analysis_with_Clinical_Trials.pdf\">\"Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Value in Health</i>. <b>8</b> (5): 521\u2013533. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1524-4733.2005.00045.x\">10.1111/j.1524-4733.2005.00045.x</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Value+in+Health&amp;rft.atitle=Good+research+practices+for+cost-effectiveness+analysis+alongside+clinical+trials%3A+The+ISPOR+RCT-CEA+task+force+report&amp;rft.volume=8&amp;rft.issue=5&amp;rft.pages=521-533&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1524-4733.2005.00045.x&amp;rft.aulast=Ramsey&amp;rft.aufirst=S&amp;rft.au=Willke%2C+R&amp;rft.au=Briggs%2C+A&amp;rft.au=Brown%2C+R&amp;rft.au=Buxton%2C+M&amp;rft.au=Chawla%2C+A&amp;rft.au=Cook%2C+J&amp;rft.au=Glick%2C+H&amp;rft.au=Liljas%2C+B&amp;rft.au=Petitti%2C+D&amp;rft.au=Reed%2C+S&amp;rft_id=http%3A%2F%2Fwww.ispor.org%2Fworkpaper%2Fresearch_practices%2FGood_Research_Practices-Cost_Effectiveness_Analysis_with_Clinical_Trials.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncremental+cost-effectiveness+ratio\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\">Wilkerson J. <a rel=\"nofollow\" class=\"external text\" href=\"http://insidehealthpolicy.com/Inside-Health-General/Public-Content/pcori-head-vows-not-to-do-cost-effectiveness-studies-but-notes-gray-areas/menu-id-869.html\">PCORI head vows not to do cost-effectiveness studies, but notes gray areas</a>. <a rel=\"nofollow\" class=\"external text\" href=\"http://InsideHealthPolicy.com\">InsideHealthPolicy.com</a>, 28 September 2011. Accessed 20 March 2012.</span>\n</li>\n</ol></div></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Health_care_quality\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Health_care_quality\" title=\"Template:Health care quality\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Health_care_quality\" title=\"Template talk:Health care quality\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Health_care_quality&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Health_care_quality\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Health_care_quality\" title=\"Health care quality\">Health care quality</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Concepts of quality</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Evidence-based_medicine\" title=\"Evidence-based medicine\">Evidence-based medicine</a></li>\n<li><a href=\"/wiki/Medical_guideline\" title=\"Medical guideline\">Medical guideline</a></li>\n<li><a href=\"/wiki/Medical_consensus\" title=\"Medical consensus\">Medical consensus</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Health care evaluations</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Clinical_audit\" title=\"Clinical audit\">Clinical audit</a></li>\n<li><a href=\"/wiki/Health_care_ratings\" title=\"Health care ratings\">Health care ratings</a></li>\n<li><a href=\"/wiki/Health_impact_assessment\" title=\"Health impact assessment\">Health impact assessment</a></li>\n<li><a href=\"/wiki/Health_services_research\" title=\"Health services research\">Health services research</a></li>\n<li><a href=\"/wiki/Routine_health_outcomes_measurement\" title=\"Routine health outcomes measurement\">Routine health outcomes measurement</a></li>\n<li><a href=\"/wiki/Independent_medical_review\" title=\"Independent medical review\">Independent medical review</a></li>\n<li><a href=\"/wiki/Clinical_peer_review\" title=\"Clinical peer review\">Clinical peer review</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Accreditation</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Hospital_accreditation\" title=\"Hospital accreditation\">Hospital accreditation</a></li>\n<li><a href=\"/wiki/International_healthcare_accreditation\" title=\"International healthcare accreditation\">International healthcare accreditation</a></li>\n<li><a href=\"/wiki/List_of_international_healthcare_accreditation_organizations\" title=\"List of international healthcare accreditation organizations\">List of international healthcare accreditation organizations</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Costs and benefits</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cost_per_procedure\" title=\"Cost per procedure\">Cost per procedure</a></li>\n<li><a href=\"/wiki/Cost-effectiveness_analysis\" title=\"Cost-effectiveness analysis\">Cost-effectiveness analysis</a></li>\n<li><a href=\"/wiki/Cost-minimization_analysis\" title=\"Cost-minimization analysis\">Cost-minimization analysis</a></li>\n<li><a class=\"mw-selflink selflink\">Incremental cost-effectiveness ratio</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Tools</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a class=\"mw-selflink selflink\">Incremental cost-effectiveness ratio</a></li>\n<li><a href=\"/wiki/Clinical_Quality_Management_System\" class=\"mw-redirect\" title=\"Clinical Quality Management System\">Clinical Quality Management System</a></li>\n<li><a href=\"/wiki/Quality-adjusted_life_year\" title=\"Quality-adjusted life year\">Quality-adjusted life year</a></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2224\nCached time: 20180913063231\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.112 seconds\nReal time usage: 0.170 seconds\nPreprocessor visited node count: 376/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 18762/2097152 bytes\nTemplate argument size: 100/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 8622/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.045/10.000 seconds\nLua memory usage: 2.44 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  100.116      1 -total\n 85.85%   85.947      1 Template:Reflist\n 59.23%   59.294      3 Template:Cite_journal\n 14.09%   14.104      1 Template:Health_care_quality\n 11.63%   11.644      1 Template:Navbox\n  7.83%    7.838      1 Template:Cite_news\n  2.31%    2.308      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:265132-0!canonical!math=5 and timestamp 20180913063231 and revision id 846906053\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D9%85%D8%B9%D8%AF%D9%84_%D9%81%D8%A7%D8%B9%D9%84%D9%8A%D8%A9_%D8%A7%D9%84%D8%AA%D9%83%D9%84%D9%81%D8%A9_%D8%A7%D9%84%D8%AA%D8%B2%D8%A7%D9%8A%D8%AF%D9%8A%D8%A9","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0645\u0639\u062f\u0644 \u0641\u0627\u0639\u0644\u064a\u0629 \u0627\u0644\u062a\u0643\u0644\u0641\u0629 \u0627\u0644\u062a\u0632\u0627\u064a\u062f\u064a\u0629"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Relaci%C3%B3n_de_coste-efectividad_incremental","langname":"Spanish","autonym":"espa\u00f1ol","*":"Relaci\u00f3n de coste-efectividad incremental"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Inkrementalny_wsp%C3%B3%C5%82czynnik_efektywno%C5%9Bci_koszt%C3%B3w","langname":"Polish","autonym":"polski","*":"Inkrementalny wsp\u00f3\u0142czynnik efektywno\u015bci koszt\u00f3w"},{"lang":"sl","url":"https://sl.wikipedia.org/wiki/Razmerje_prirastka_stro%C5%A1kov_glede_na_prirastek_u%C4%8Dinkovitosti","langname":"Slovenian","autonym":"sloven\u0161\u010dina","*":"Razmerje prirastka stro\u0161kov glede na prirastek u\u010dinkovitosti"}],"categories":[{"sortkey":"Incremental Cost-Effectiveness Ratio","*":"Costs"},{"sortkey":"Incremental Cost-Effectiveness Ratio","*":"Health_economics"},{"sortkey":"Incremental Cost-Effectiveness Ratio","*":"Healthcare_quality"}],"links":[{"ns":10,"exists":"","*":"Template:Health care quality"},{"ns":0,"exists":"","*":"Clinical Quality Management System"},{"ns":0,"exists":"","*":"Clinical audit"},{"ns":0,"exists":"","*":"Clinical peer review"},{"ns":0,"exists":"","*":"Clinical trials"},{"ns":0,"exists":"","*":"Cost-effectiveness analysis"},{"ns":0,"exists":"","*":"Cost-minimization analysis"},{"ns":0,"exists":"","*":"Cost per procedure"},{"ns":0,"exists":"","*":"Cost\u2013utility analysis"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Evidence-based medicine"},{"ns":0,"exists":"","*":"Health care costs"},{"ns":0,"exists":"","*":"Health care quality"},{"ns":0,"exists":"","*":"Health care ratings"},{"ns":0,"exists":"","*":"Health care rationing"},{"ns":0,"exists":"","*":"Health impact assessment"},{"ns":0,"exists":"","*":"Health services research"},{"ns":0,"exists":"","*":"Hospital accreditation"},{"ns":0,"exists":"","*":"Independent medical review"},{"ns":0,"exists":"","*":"International healthcare accreditation"},{"ns":0,"exists":"","*":"List of international healthcare accreditation organizations"},{"ns":0,"exists":"","*":"Medical consensus"},{"ns":0,"exists":"","*":"Medical guideline"},{"ns":0,"exists":"","*":"National Health Service"},{"ns":0,"exists":"","*":"National Institute for Health and Care Excellence"},{"ns":0,"exists":"","*":"Patient-Centered Outcomes Research Institute"},{"ns":0,"exists":"","*":"Patient Protection and Affordable Care Act"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Quality-adjusted life year"},{"ns":0,"exists":"","*":"Quality-adjusted life years"},{"ns":0,"exists":"","*":"Routine health outcomes measurement"},{"ns":0,"exists":"","*":"Willingness-to-pay"},{"ns":11,"exists":"","*":"Template talk:Health care quality"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Health care quality"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Arguments"}],"images":["Lock-green.svg"],"externallinks":["http://www.gabionline.net/Generics/General/What-is-the-incremental-cost-effectiveness-ratio-ICER","http://www.bmj.com/content/335/7616/358","//doi.org/10.1136/bmj.39308.560069.BE","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1952475","//www.ncbi.nlm.nih.gov/pubmed/17717337","http://pharmaphorum.com/views-and-analysis/three-nice-thresholds-for-cost-effectiveness-does-that-make-sense/","http://www.nejm.org/doi/full/10.1056/NEJMp078190","//doi.org/10.1056/NEJMp078190","http://knowledge.wharton.upenn.edu/article.cfm?articleid=1949","http://www.ispor.org/workpaper/research_practices/Good_Research_Practices-Cost_Effectiveness_Analysis_with_Clinical_Trials.pdf","//doi.org/10.1111/j.1524-4733.2005.00045.x","http://insidehealthpolicy.com/Inside-Health-General/Public-Content/pcori-head-vows-not-to-do-cost-effectiveness-studies-but-notes-gray-areas/menu-id-869.html","http://InsideHealthPolicy.com"],"sections":[{"toclevel":1,"level":"2","line":"Use as a decision rule","number":"1","index":"1","fromtitle":"Incremental_cost-effectiveness_ratio","byteoffset":1300,"anchor":"Use_as_a_decision_rule"},{"toclevel":1,"level":"2","line":"Controversies","number":"2","index":"2","fromtitle":"Incremental_cost-effectiveness_ratio","byteoffset":4764,"anchor":"Controversies"},{"toclevel":1,"level":"2","line":"References","number":"3","index":"3","fromtitle":"Incremental_cost-effectiveness_ratio","byteoffset":7170,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Incremental cost-effectiveness ratio","iwlinks":[],"properties":[{"name":"defaultsort","*":"Incremental Cost-Effectiveness Ratio"},{"name":"wikibase_item","*":"Q6015473"}]}}